금융 뉴스 허브

Exchange-Traded Funds Fall as US Equities Drop Midday on Labor Data, Iran Tumult

Broad Market Indicators Broad-market exchange-traded funds IWM and IVV fell. Actively traded I

Beef is very expensive right now — and Shake Shack just lost money for the first time in years

The burger chain’s shares were dropping nearly 30% in the face of cost inflation and challenging consumer sentiment.

Stock Market Today, May 7: Rally Slows at Midday as Investors Watch Iran Developments

Arm Holdings tumbled on demand concerns, and markets await progress on reopening the Strait of Hormuz, today, May 7, 2026.

The Dow Falls 100 Points. It Can't Stay Above 50,000.

The Dow just can’t keep above 50,000. The blue-chip index was down 200 points, or 0.4%, to 49,718 after trading as high as 50,130. The S&P 500 was down 0.3%. The Nasdaq was down 0.2%. A slide in chip ...

Optimum anticipates $1.2B-$1.5B 2026 capex while projecting mid-single-digit revenue declines

BXSL Q1 2026 Earnings Transcript

Brad Marshall: Thank you, and good morning. Looking at the leveraged loan index, spreads widened roughly 50 basis points and returns were down 55 basis points during the quarter. Despite private cre ...

Zoetis Is Today’s Worst S&P 500 Stock. Why the Quarter Is ‘Worse Than It Seems.’

Shares of Zoetis plummeted Thursday, after the animal-health company’s results missed Wall Street expectations and cut its full-year guidance. Zoetis stock sank 20% to $88.94 on Thursday, making i ...

The number of people getting unemployment checks just fell to a 2½-year low. Here’s why.

Is it getting easier to find a job? Maybe. A sluggish U.S. labor market appears to be coming out of its torpor.

BYND slips on soft guidance amid continued plant-based demand weakness

Arm has a ton of chip demand. There’s just one problem.

Arm’s stock was falling, with analysts noting the company hasn’t yet secured manufacturing capacity for all its fresh CPU demand.

Americans are behaving like they’re in a recession, Whirlpool warns

Whirlpool’s stock is sinking as customers dramatically cut back on discretionary appliance purchases.

Sarepta Stock Slumps. Why an Earnings Beat Wasn’t Enough for the S&P 500 Loser.

Sarepta Therapeutics is seeing lower demand for its flagship gene therapy, Elevidys, following a regulatory crackdown.